The United Laboratories International Holdings Limited (HKG:3933)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.23
+0.01 (0.12%)
Jun 26, 2026, 4:08 PM HKT
-46.07%
Market Cap 16.24B
Revenue (ttm) 14.70B
Net Income (ttm) 2.32B
Shares Out 1.97B
EPS (ttm) 1.23
PE Ratio 6.68
Forward PE 9.58
Dividend 0.48 (5.89%)
Ex-Dividend Date Jul 7, 2026
Volume 9,463,940
Average Volume 8,261,926
Open 8.23
Previous Close 8.22
Day's Range 8.04 - 8.31
52-Week Range 7.98 - 17.98
Beta 0.31
RSI 37.90
Earnings Date Aug 28, 2026

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-... [Read more]

Sector Healthcare
Founded 1990
Employees 18,000
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3933
Full Company Profile

Financial Performance

In 2025, HKG:3933's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for 3933 stock is "Strong Buy." The 12-month stock price target is $15.64, which is an increase of 90.04% from the latest price.

Price Target
$15.64
(90.04% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

The United Laboratories International Holdings Earnings release: H2 2025

The United Laboratories International Holdings released its H2 2025 earnings on March 24, 2026, summarizing the period's financial results.

3 months ago - Filings

The United Laboratories International Holdings Slides: H2 2025

The United Laboratories International Holdings has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.

3 months ago - Filings

The United Laboratories International Holdings Annual report: H2 2025

The United Laboratories International Holdings has published its H2 2025 annual report on March 24, 2026.

3 months ago - Filings

The United Laboratories International Holdings Quarterly report: H1 2025

The United Laboratories International Holdings has published its H1 2025 quarterly earnings report on August 28, 2025.

10 months ago - Filings

The United Laboratories International Holdings Earnings release: H1 2025

The United Laboratories International Holdings released its H1 2025 earnings on August 28, 2025, summarizing the period's financial results.

10 months ago - Filings

The United Laboratories International Holdings Slides: H1 2025

The United Laboratories International Holdings has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 28, 2025.

10 months ago - Filings